|
US670417A
(en)
|
1899-08-30 |
1901-03-26 |
Cronk Hanger Co |
Hand-rake.
|
|
US3270960A
(en)
|
1964-09-11 |
1966-09-06 |
Sperry Rand Corp |
Fluid sensor
|
|
US3773919A
(en)
|
1969-10-23 |
1973-11-20 |
Du Pont |
Polylactide-drug mixtures
|
|
US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
|
JPS6023084B2
(ja)
|
1979-07-11 |
1985-06-05 |
味の素株式会社 |
代用血液
|
|
US4485045A
(en)
|
1981-07-06 |
1984-11-27 |
Research Corporation |
Synthetic phosphatidyl cholines useful in forming liposomes
|
|
JPS5896026A
(ja)
|
1981-10-30 |
1983-06-07 |
Nippon Chemiphar Co Ltd |
新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
|
|
US4640835A
(en)
|
1981-10-30 |
1987-02-03 |
Nippon Chemiphar Company, Ltd. |
Plasminogen activator derivatives
|
|
DE3380726D1
(en)
|
1982-06-24 |
1989-11-23 |
Japan Chem Res |
Long-acting composition
|
|
DD266710A3
(de)
|
1983-06-06 |
1989-04-12 |
Ve Forschungszentrum Biotechnologie |
Verfahren zur biotechnischen Herstellung van alkalischer Phosphatase
|
|
US4544545A
(en)
|
1983-06-20 |
1985-10-01 |
Trustees University Of Massachusetts |
Liposomes containing modified cholesterol for organ targeting
|
|
US4496689A
(en)
|
1983-12-27 |
1985-01-29 |
Miles Laboratories, Inc. |
Covalently attached complex of alpha-1-proteinase inhibitor with a water soluble polymer
|
|
US5019369A
(en)
|
1984-10-22 |
1991-05-28 |
Vestar, Inc. |
Method of targeting tumors in humans
|
|
US4879231A
(en)
|
1984-10-30 |
1989-11-07 |
Phillips Petroleum Company |
Transformation of yeasts of the genus pichia
|
|
EP0206448B1
(en)
|
1985-06-19 |
1990-11-14 |
Ajinomoto Co., Inc. |
Hemoglobin combined with a poly(alkylene oxide)
|
|
US4766106A
(en)
|
1985-06-26 |
1988-08-23 |
Cetus Corporation |
Solubilization of proteins for pharmaceutical compositions using polymer conjugation
|
|
US5057313A
(en)
|
1986-02-25 |
1991-10-15 |
The Center For Molecular Medicine And Immunology |
Diagnostic and therapeutic antibody conjugates
|
|
WO1987005330A1
(en)
|
1986-03-07 |
1987-09-11 |
Michel Louis Eugene Bergh |
Method for enhancing glycoprotein stability
|
|
GB8610600D0
(en)
|
1986-04-30 |
1986-06-04 |
Novo Industri As |
Transformation of trichoderma
|
|
US4791192A
(en)
|
1986-06-26 |
1988-12-13 |
Takeda Chemical Industries, Ltd. |
Chemically modified protein with polyethyleneglycol
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4837028A
(en)
|
1986-12-24 |
1989-06-06 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
ATE106249T1
(de)
|
1987-11-05 |
1994-06-15 |
Hybritech Inc |
Polysaccharidmodifizierte immunglobuline mit reduziertem immunogenem potential oder verbesserter pharmakokinetik.
|
|
US5283187A
(en)
|
1987-11-17 |
1994-02-01 |
Brown University Research Foundation |
Cell culture-containing tubular capsule produced by co-extrusion
|
|
US4892538A
(en)
|
1987-11-17 |
1990-01-09 |
Brown University Research Foundation |
In vivo delivery of neurotransmitters by implanted, encapsulated cells
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
|
US5013556A
(en)
|
1989-10-20 |
1991-05-07 |
Liposome Technology, Inc. |
Liposomes with enhanced circulation time
|
|
IL99552A0
(en)
|
1990-09-28 |
1992-08-18 |
Ixsys Inc |
Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
|
|
EP0646178A1
(en)
|
1992-06-04 |
1995-04-05 |
The Regents Of The University Of California |
expression cassette with regularoty regions functional in the mammmlian host
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
WO1994012520A1
(en)
|
1992-11-20 |
1994-06-09 |
Enzon, Inc. |
Linker for linked fusion polypeptides
|
|
US5747654A
(en)
|
1993-06-14 |
1998-05-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Recombinant disulfide-stabilized polypeptide fragments having binding specificity
|
|
US5443953A
(en)
|
1993-12-08 |
1995-08-22 |
Immunomedics, Inc. |
Preparation and use of immunoconjugates
|
|
DE4343591A1
(de)
|
1993-12-21 |
1995-06-22 |
Evotec Biosystems Gmbh |
Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes
|
|
US5605793A
(en)
|
1994-02-17 |
1997-02-25 |
Affymax Technologies N.V. |
Methods for in vitro recombination
|
|
US6306393B1
(en)
|
1997-03-24 |
2001-10-23 |
Immunomedics, Inc. |
Immunotherapy of B-cell malignancies using anti-CD22 antibodies
|
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
|
US8236561B2
(en)
|
1999-04-15 |
2012-08-07 |
Crucell Holland B.V. |
Efficient production of IgA in recombinant mammalian cells
|
|
EP1212366B1
(en)
|
1999-07-30 |
2007-09-12 |
Medarex, Inc. |
Therapeutic compounds comprised of anti-fc receptor binding agents
|
|
US8372954B2
(en)
|
2000-12-22 |
2013-02-12 |
National Research Council Of Canada |
Phage display libraries of human VH fragments
|
|
AU2002310497A1
(en)
|
2001-06-20 |
2003-01-08 |
Caprion Pharmaceuticals Inc. |
Protein aggregation assays and uses thereof
|
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
|
EP1514107B1
(en)
|
2002-06-03 |
2013-05-15 |
The Institute for Systems Biology |
Methods for quantitative proteome analysis of glycoproteins
|
|
DE602004017726D1
(de)
|
2003-06-30 |
2008-12-24 |
Domantis Ltd |
Pegylierte Single-domain-antikörper (dAb)
|
|
US7850962B2
(en)
|
2004-04-20 |
2010-12-14 |
Genmab A/S |
Human monoclonal antibodies against CD20
|
|
US7894724B2
(en)
|
2005-03-31 |
2011-02-22 |
Ciena Corporation |
Method and apparatus for improving dual-polarization optical communication performance
|
|
PT1999154E
(pt)
|
2006-03-24 |
2013-01-24 |
Merck Patent Gmbh |
Domínios proteicos heterodiméricos modificados
|
|
EP1916257A1
(en)
|
2006-10-27 |
2008-04-30 |
Charite-Universitätsmedizin Berlin |
GD2 peptide mimotopes for anticancer vaccination
|
|
US8313730B2
(en)
|
2006-12-13 |
2012-11-20 |
Michael R. Simon |
Treatment of celiac disease with IgA
|
|
US20090075378A1
(en)
|
2007-02-20 |
2009-03-19 |
Anaptysbio, Inc. |
Somatic hypermutation systems
|
|
GB0812478D0
(en)
|
2008-07-09 |
2008-08-13 |
Rolls Royce Plc |
An apparatus and a method of measuring erosion of an edge of a turbomachine aerofoil
|
|
CA2737241C
(en)
|
2008-09-26 |
2017-08-29 |
Ucb Pharma S.A. |
Multivalent antibody fusion proteins
|
|
AU2015200990B2
(en)
*
|
2009-03-20 |
2016-07-21 |
Laboratoire Français Du Fractionnement Et Des Biotechnologies |
Optimized Fc variants
|
|
WO2010127369A1
(en)
|
2009-05-01 |
2010-11-04 |
Rational Biotechnology Inc. |
Eit (electrical impedance tomography) guided sonoporation, ultrasound tissue ablation and their use thereof
|
|
CN102549016B
(zh)
*
|
2009-06-30 |
2015-05-06 |
研究发展基金会 |
免疫球蛋白fc多肽
|
|
EP2578681B1
(en)
|
2010-05-24 |
2015-07-01 |
Kagoshima University |
Iga-binding peptide and iga purification using same
|
|
TWI452136B
(zh)
*
|
2010-11-17 |
2014-09-11 |
中外製藥股份有限公司 |
A multiple specific antigen-binding molecule that replaces the function of Factor VIII in blood coagulation
|
|
EP2465536A1
(en)
|
2010-12-14 |
2012-06-20 |
CSL Behring AG |
CD89 activation in therapy
|
|
US8790651B2
(en)
*
|
2011-07-21 |
2014-07-29 |
Zoetis Llc |
Interleukin-31 monoclonal antibody
|
|
EP2791170A1
(en)
|
2011-12-16 |
2014-10-22 |
Synthon Biopharmaceuticals B.V. |
Compounds and methods for treating inflammatory diseases
|
|
EP2636681A1
(en)
|
2012-03-09 |
2013-09-11 |
CSL Behring AG |
Process for enriching IgA
|
|
BR112014022240A2
(pt)
|
2012-03-09 |
2017-08-01 |
Csl Behring Ag |
composições compreendendo imunoglobulinas semelhantes à secretoras
|
|
PL3366705T3
(pl)
*
|
2012-09-12 |
2023-09-18 |
Genzyme Corporation |
FC zawierające polipeptydy o zmienionej glikozylacji i zmniejszonej funkcji efektorowej
|
|
US9890216B2
(en)
|
2012-10-23 |
2018-02-13 |
Board Of Regents, The University Of Texas System |
Antibodies with engineered IgG Fc domains
|
|
DK3725807T3
(da)
|
2012-12-03 |
2026-01-12 |
Novimmune Sa |
Anti-cd47 antistoffer og fremgangsmåder til anvendelse deraf
|
|
CN106456749B
(zh)
|
2014-03-11 |
2021-03-30 |
小利兰·斯坦福大学托管委员会 |
抗SIRPα抗体和双特异性巨噬细胞增强型抗体
|
|
US10925962B2
(en)
|
2014-07-18 |
2021-02-23 |
Nippi, Incorporated |
Polymeric IgA-type recombinant antibody and use thereof
|
|
CA3035427A1
(en)
|
2016-09-01 |
2018-03-08 |
Umc Utrecht Holding B.V. |
Cd20 antibodies
|
|
EP3747438A1
(en)
|
2017-07-24 |
2020-12-09 |
Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis |
Treating pathological conditions by direct and indirect targeting of sirpa - cd47 interaction
|
|
EP3684818A2
(en)
*
|
2017-09-21 |
2020-07-29 |
UMC Utrecht Holding B.V. |
Anti-gd2 antibody for the treatment of neuroblastoma
|
|
CN113260632A
(zh)
*
|
2018-10-29 |
2021-08-13 |
蒂嘉特克斯公司 |
包含IgA抗体构建体的组合物和方法
|
|
BR112021014276A2
(pt)
|
2019-01-22 |
2021-09-28 |
Genentech, Inc. |
Anticorpos iga isolados, moléculas de fusão igg-iga isoladas, ácido nucleico isolado, célula hospedeira, método para produzir um anticorpo, para tratar um indivíduo, para aumentar a expressão de dímeros, trímeros ou tetrâmeros, para aumentar a produção de polímeros, para aumentar a produção de dímeros, para aumentar a produção de um polímero, para diminuir a produção de polímeros, para aumentar a expressão transitória de um anticorpo, para expressar dímeros de moléculas de fusão, para expressar dímeros, trímeros ou tetrâmeros, para purificar um anticorpo, para purificar um estado oligomérico de um anticorpo, composição farmacêutica e uso do anticorpo
|
|
CN114096559B
(zh)
*
|
2019-03-27 |
2026-03-20 |
蒂嘉特克斯公司 |
工程化iga抗体及其使用方法
|